Columbia Care To Raise $25.2 Million In Bought Deal Financing

Columbia Care (CSE: CCHW) is the latest firm to announce a financing. The company this morning announced that it will be conducting a bought deal financing to raise gross proceeds of $25.2 million in a financing lad by Canaccord Genuity.

The financing will see a total of 2.8 million shares of the issuer sold at a price of $9.00 per share to raise gross proceeds of $25.2 million. No warrant is to be issued in connection with the offering, with the offering expected to be sold primarily to one large institutional investor, however a name was not provided.

An over-allotment option has also been granted by the company, valid until the closing of the offering.

Proceeds from the financing are to be used for working capital and general corporate purposes.

The financing is expected to close February 25, 2021.

Columbia Care last traded at $9.78 on the CSE.


Information for this briefing was found via Sedar and Columbia Care Inc. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

First Majestic Q1 Earnings: A Bang Up Quarter

Copper’s Structural Shortage May Be Here to Stay | Colin Joudrie – Selkirk Copper

Why Barrick’s “Strong” Quarter Wasn’t So Strong | Q1 2026 Earnings

Recommended

Questcorp Wraps Expanded Drone Survey at La Union as Summer Drilling Approaches

Altamira Gold Extends Maria Bonita Footprint with 110 Metre Step-Out

Related News

Canaccord Lowers Targets On Numerous Top Level Cannabis Equities

On February 4th, Canaccord Genuity came out with their cannabis fourth quarter 2021 preview. On...

Monday, February 7, 2022, 01:30:00 PM

Columbia Care Reports $132.3 Million In Q3 Revenues, Lowers 2021 Guidance

Columbia Care (NEO: CCHW) reported its third quarter financial results this morning, posting record quarterly...

Friday, November 12, 2021, 09:11:20 AM

Cresco Labs: Stifel Slashes Price Target From $30 To $8 Following Poor Q4 Results

On March 23rd, Cresco Labs (CSE: CL) announced its fourth-quarter financial results, which disappointed many...

Friday, March 25, 2022, 03:39:00 PM

Columbia Care: Canaccord Drops Price Target To $13

On November 12th, Columbia Care (NEO: CCHW) reported its third quarter financial results. The company...

Sunday, November 21, 2021, 04:52:00 PM

Canaccord Reiterates Columbia Care As A Cannabis Top Pick

Columbia Care (NEO: CCHW) reported its first quarter financial results on May 17th. The company...

Thursday, May 20, 2021, 04:41:00 PM